BIT Capital GmbH
Source: SEC Form 13F · as of Mar 2026BIT Capital GmbH holds 16 biotech & pharma companies tracked by BioSniper, totaling $22.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$22.7M
| Company | Shares | Value |
|---|---|---|
| RIOTRiot Platforms, Inc. | 813,835 | $10.1M |
| DFTXDefinium Therapeutics Inc. | 277,511 | $5.2M |
| NKTRNEKTAR THERAPEUTICS | 21,100 | $1.5M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 12,000 | $1.0M |
| BNTXBioNTech SE | 9,147 | $813K |
| ATAIAtai Beckley N.V. | 182,576 | $646K |
| RVMDREVOLUTION MEDICINES, INC. | 5,700 | $554K |
| TRVITrevi Therapeutics, Inc. | 45,000 | $537K |
| ELDNEledon Pharmaceuticals, Inc. | 134,000 | $413K |
| RAREUltragenyx Pharmaceutical Inc. | 18,000 | $377K |
| FULCFulcrum Therapeutics, Inc. | 40,000 | $307K |
| ANNXAnnexon, Inc. | 50,000 | $277K |
| PALIPALISADE BIO, INC. | 155,000 | $271K |
| VIRVir Biotechnology, Inc. | 30,000 | $269K |
| KNSAKiniksa Pharmaceuticals International, plc | 5,138 | $247K |
| PMVPPMV Pharmaceuticals, Inc. | 123,555 | $153K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.